Eugene J H Wee (31 results)
- Hardcover
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.Romtrade Corp.
Contact seller5-star sellerCondition: New
£ 91.88
Free ShippingShips within U.S.A.Quantity: 1 available
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
- Hardcover
Seller: Basi6 International, Irving, TX, U.S.A.Basi6 International
Contact seller5-star sellerCondition: New
£ 92.20
Free ShippingShips within U.S.A.Quantity: 1 available
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
- Softcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: New
£ 94.16
£ 2.92 shippingShips within U.S.A.Quantity: 4 available
Condition: New. pp. 188.
- Hardcover
Seller: Basi6 International, Irving, TX, U.S.A.Basi6 International
Contact seller5-star sellerCondition: New
£ 100.73
Free ShippingShips within U.S.A.Quantity: 1 available
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 53.79
£ 59.88 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Promoter DNA Methylation of miRNAs as Breast Cancer Biomarkers | From biomarker discovery to biotechnology development | Eugene J. H. Wee | Taschenbuch | 188 S. | Englisch | 2013 | LAP LAMBERT Academic Publishing | EAN 9783659505072 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengerich…er Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
- Hardcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: Used
£ 118.51
£ 2.92 shippingShips within U.S.A.Quantity: 1 available
Condition: Used. pp. 210 Index.
- Hardcover
Seller: Majestic Books, Hounslow, United KingdomMajestic Books
Contact seller4-star sellerCondition: Used
£ 121.78
£ 6.50 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Condition: Used. pp. 210.
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Shiddiky, Muhammad J. A. (EDT); Wee, Eugene J. H. (EDT); Rauf, Sakandar (EDT); Trau, Matt (EDT)
- Hardcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: New
£ 135.59
£ 1.93 shippingShips within U.S.A.Quantity: 3 available
Condition: New.
- Hardcover
Seller: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US
Contact seller5-star sellerCondition: New
£ 137.59
Free ShippingShips within U.S.A.Quantity: 3 available
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Wee Eugene J.H. Shiddiky Muhammad J.A. Trau Matt Rauf Sakandar
- Hardcover
Seller: Biblios, frankfurt am main, HESSE, GermanyBiblios
Contact seller4-star sellerCondition: Used
£ 129.54
£ 8.51 shippingShips from Germany to U.S.A.Quantity: 1 available
Condition: Used. pp. 210.
- Hardcover
Seller: PBShop.store UK, Fairford, GLOS, United KingdomPBShop.store UK
Contact seller5-star sellerCondition: New
£ 144.47
£ 5.02 shippingShips from United Kingdom to U.S.A.Quantity: 3 available
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Shiddiky, Muhammad J. A. (EDT); Wee, Eugene J. H. (EDT); Rauf, Sakandar (EDT); Trau, Matt (EDT)
- Hardcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: New
£ 137.65
£ 15.00 shippingShips from United Kingdom to U.S.A.Quantity: 3 available
Condition: New.
- Hardcover
- First Edition
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrelandKennys Bookshop and Art Galleries Ltd.
Contact seller5-star sellerCondition: New
£ 150.49
£ 8.13 shippingShips from Ireland to U.S.A.Quantity: 2 available
Condition: New. Editor(s): Shiddiky, Muhammad J. A.; Wee, Eugene J. H.; Rauf, Sakandar; Trau, Matt. Num Pages: 227 pages. BIC Classification: MBGR. Category: (P) Professional & Vocational. Dimension: 258 x 183 x 18. Weight in Grams: 556. . 2013. 1st Edition. Hardcover. . . . .
- Hardcover
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail
Contact seller5-star sellerCondition: New
£ 160.92
Free ShippingShips within U.S.A.Quantity: 1 available
Hardcover. Condition: new. Hardcover. In recent years, thousands of cancer biomarkers have been discovered and described in scientific literature. The promise of personalised medicine, where diseases such as cancer are accurately diagnosed and treatments tailored specifically for individuals, is becoming a reality. Significant a…dvances in biomarker-based research methodologies such as Next Generation Sequencing (NGS) are at the cusp of ushering in a new era of personal medicine. However, unlike the spectacular advances in research technologies for disease biomarker discovery, biomarker-based technologies that can effectively be used in the clinic (or point-of-care) to enable personalised medicine are still lacking. In this book, we feature a selection of emerging technologies which are aimed at enabling clinical applications of personalised medicine. Each of the eight chapters is written by a leading group at the intersection of microfluidics, biology, and nanotechnology.For instance, to accelerate a major bottleneck in the development of clinically useful protein diagnostics, we discuss the application of yeast-derived single chain Fragment variable (scFv) antibody-like molecules as a potential low cost alternative to traditional antibody-based diagnostics. Circulating tumour cells (CTCs) are an emerging class of cancer biomarkers and a potential resource for understanding cancer progression; we explore various strategies combining microfluidics with nanotechnology for capturing CTCs. The book includes an evaluation of some current and emerging technologies for detecting clinical DNA methylation, another potential cancer biomarker. As personalised medicine may involve tracking a patient's response to treatment, the application of microfluidics to detect metabolites in biological fluids is also discussed. Finally, the ultimate goal of personalised medicine is targeted therapy. One promising approach is RNAi technology which uses short nucleotides to disrupt cancer pathways. In this book, nanoparticle approaches to deliver these short nucleotides are discussed. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Shiddiky, Muhammad J. A. (EDT); Wee, Eugene J. H. (EDT); Rauf, Sakandar (EDT); Trau, Matt (EDT)
- Hardcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: Used - As new
£ 160.86
£ 1.93 shippingShips within U.S.A.Quantity: 3 available
Condition: As New. Unread book in perfect condition.
Microfluidics, Nanotechnology and Disease Biomarkers for Personalized Medicine Applications
Shiddiky, Muhammad J. A. (EDT); Wee, Eugene J. H. (EDT); Rauf, Sakandar (EDT); Trau, Matt (EDT)
- Hardcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: Used - As new
£ 156.76
£ 15.00 shippingShips from United Kingdom to U.S.A.Quantity: 3 available
Condition: As New. Unread book in perfect condition.
- Hardcover
Seller: Rarewaves.com USA, London, LONDO, United KingdomRarewaves.com USA
Contact seller5-star sellerCondition: New
£ 181.06
Free ShippingShips from United Kingdom to U.S.A.Quantity: 2 available
Hardback. Condition: New.
- Hardcover
Seller: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contact seller5-star sellerCondition: New
£ 181.60
£ 7.69 shippingShips within U.S.A.Quantity: 2 available
Condition: New. Editor(s): Shiddiky, Muhammad J. A.; Wee, Eugene J. H.; Rauf, Sakandar; Trau, Matt. Num Pages: 227 pages. BIC Classification: MBGR. Category: (P) Professional & Vocational. Dimension: 258 x 183 x 18. Weight in Grams: 556. . 2013. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
- Hardcover
Seller: moluna, Greven, Germanymoluna
Contact seller5-star sellerCondition: New
£ 165.29
£ 41.91 shippingShips from Germany to U.S.A.Quantity: 3 available
Gebunden. Condition: New. KlappentextrnrnIn recent years, thousands of cancer biomarkers have been discovered and described in scientific literature. The promise of personalised medicine, where diseases such as cancer are accurately diagnosed and treatments tailored spec.
- Hardcover
Seller: Gazelle Books, Lancaster, LANCA, United KingdomGazelle Books
Contact seller4-star sellerCondition: New
£ 146.24
£ 55.00 shippingShips from United Kingdom to U.S.A.Quantity: 3 available
Hardback. Condition: New. New Book, Direct from Publisher.
- Hardcover
Seller: THE SAINT BOOKSTORE, Southport, United KingdomTHE SAINT BOOKSTORE
Contact seller5-star sellerCondition: New
£ 190.84
£ 16.95 shippingShips from United Kingdom to U.S.A.Quantity: 3 available
Hardback. Condition: New. New copy - Usually dispatched within 4 working days.
- Hardcover
Seller: Rarewaves.com UK, London, United KingdomRarewaves.com UK
Contact seller5-star sellerCondition: New
£ 173.68
£ 65.00 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Hardback. Condition: New.
- Hardcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 203.93
£ 53.70 shippingShips from Germany to U.S.A.Quantity: 2 available
Buch. Condition: Neu. Neuware - In recent years, thousands of cancer biomarkers have been discovered and described in scientific literature. The promise of personalised medicine, where diseases such as cancer are accurately diagnosed and treatments tailored specifically for individuals, is becoming a reality. Significant advance…s in biomarker-based research methodologies such as Next Generation Sequencing (NGS) are at the cusp of ushering in a new era of personal medicine. However, unlike the spectacular advances in research technologies for disease biomarker discovery, biomarker-based technologies that can effectively be used in the clinic (or point-of-care) to enable personalised medicine are still lacking. In this book, we feature a selection of emerging technologies which are aimed at enabling clinical applications of personalised medicine. Each of the eight chapters is written by a leading group at the intersection of microfluidics, biology, and nanotechnology. For instance, to accelerate a major bottleneck in the development of clinically useful protein diagnostics, we discuss the application of yeast-derived single chain Fragment variable (scFv) antibody-like molecules as a potential low cost alternative to traditional antibody-based diagnostics. Circulating tumour cells (CTCs) are an emerging class of cancer biomarkers and a potential resource for understanding cancer progression; we explore various strategies combining microfluidics with nanotechnology for capturing CTCs. The book includes an evaluation of some current and emerging technologies for detecting clinical DNA methylation, another potential cancer biomarker. As personalised medicine may involve tracking a patient's response to treatment, the application of microfluidics to detect metabolites in biological fluids is also discussed. Finally, the ultimate goal of personalised medicine is targeted therapy. One promising approach is RNAi technology which uses short nucleotides to disrupt cancer pathways. In this book, nanoparticle approaches to deliver these short nucleotides are discussed.
- Hardcover
Seller: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contact seller5-star sellerCondition: New
£ 240.61
£ 27.11 shippingShips from Australia to U.S.A.Quantity: 1 available
Hardcover. Condition: new. Hardcover. In recent years, thousands of cancer biomarkers have been discovered and described in scientific literature. The promise of personalised medicine, where diseases such as cancer are accurately diagnosed and treatments tailored specifically for individuals, is becoming a reality. Significant a…dvances in biomarker-based research methodologies such as Next Generation Sequencing (NGS) are at the cusp of ushering in a new era of personal medicine. However, unlike the spectacular advances in research technologies for disease biomarker discovery, biomarker-based technologies that can effectively be used in the clinic (or point-of-care) to enable personalised medicine are still lacking. In this book, we feature a selection of emerging technologies which are aimed at enabling clinical applications of personalised medicine. Each of the eight chapters is written by a leading group at the intersection of microfluidics, biology, and nanotechnology.For instance, to accelerate a major bottleneck in the development of clinically useful protein diagnostics, we discuss the application of yeast-derived single chain Fragment variable (scFv) antibody-like molecules as a potential low cost alternative to traditional antibody-based diagnostics. Circulating tumour cells (CTCs) are an emerging class of cancer biomarkers and a potential resource for understanding cancer progression; we explore various strategies combining microfluidics with nanotechnology for capturing CTCs. The book includes an evaluation of some current and emerging technologies for detecting clinical DNA methylation, another potential cancer biomarker. As personalised medicine may involve tracking a patient's response to treatment, the application of microfluidics to detect metabolites in biological fluids is also discussed. Finally, the ultimate goal of personalised medicine is targeted therapy. One promising approach is RNAi technology which uses short nucleotides to disrupt cancer pathways. In this book, nanoparticle approaches to deliver these short nucleotides are discussed. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
- Hardcover
Seller: BOOKIT!, Genève, SwitzerlandBOOKIT!
Contact seller3-star sellerCondition: Used - As new
£ 535.83
£ 45.77 shippingShips from Switzerland to U.S.A.Quantity: 1 available
Condition: Used: Like New. LIVRE A L?ETAT DE NEUF. EXPEDIE SOUS 3 JOURS OUVRES. NUMERO DE SUIVI COMMUNIQUE AVANT ENVOI, EMBALLAGE RENFORCE. EAN:9781628080209.
Language: English
Published by LAP LAMBERT Academic Publishing Dez 2013, 2013
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
£ 63.36
£ 19.68 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Breast cancer is a complex disease with many factors that can contribute to its development. As such, informative biomarkers are required to accurately and comprehensively characterize breast cancer so that patient management is bot…h informed and optimal. Current breast cancer biomarkers, although useful, have limitations and are sometimes unable to classify all breast cancer patients. Therefore, new classes of biomarkers and detection tools are needed. A possible complement to existing biomarkers is the aberrant DNA methylation of miRNA promoters in breast cancer. This book will take the reader on a journey from discovering a novel biomarker to developing a new technology for detecting this potential biomarker in clinical practice. The genetics/biotechnology interdisciplinary combination may appeal to readers majoring in either field and to anyone interested in interdisciplinary research. 188 pp. Englisch.
- Softcover
- Print on Demand
Seller: moluna, Greven, Germanymoluna
Contact seller5-star sellerCondition: New
£ 51.21
£ 41.91 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Wee Eugene J.H.Eugene J.H. Wee, PhD in cancer genetics from The University of Queensland, Australia. Postdoctoral researcher at the Australian Institute for Bioengineering and Nanotechnology.Breast canc…er is a complex disease wit.
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
- Softcover
- Print on Demand
Seller: Majestic Books, Hounslow, United KingdomMajestic Books
Contact seller4-star sellerCondition: New
£ 96.18
£ 6.50 shippingShips from United Kingdom to U.S.A.Quantity: 4 available
Condition: New. Print on Demand pp. 188 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
- Softcover
- Print on Demand
Seller: Biblios, frankfurt am main, HESSE, GermanyBiblios
Contact seller4-star sellerCondition: New
£ 102.58
£ 8.51 shippingShips from Germany to U.S.A.Quantity: 4 available
Condition: New. PRINT ON DEMAND pp. 188.
Language: English
Published by LAP LAMBERT Academic Publishing Dez 2013, 2013
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
£ 63.36
£ 51.33 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Breast cancer is a complex disease with many factors that can contribute to its development. As such, informative biomarkers are required to accurately and comprehensively characterize breast cancer so that patient management is both in…formed and optimal. Current breast cancer biomarkers, although useful, have limitations and are sometimes unable to classify all breast cancer patients. Therefore, new classes of biomarkers and detection tools are needed. A possible complement to existing biomarkers is the aberrant DNA methylation of miRNA promoters in breast cancer. This book will take the reader on a journey from discovering a novel biomarker to developing a new technology for detecting this potential biomarker in clinical practice. The genetics/biotechnology interdisciplinary combination may appeal to readers majoring in either field and to anyone interested in interdisciplinary research.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 188 pp. Englisch.
